Having established that i.v. iron treatment in vivo can correct intracellular iron levels in PASMCs, we tested whether it could also prevent or reverse PAH in fpnC326Yfl/fl SMMHC-CreERT2+ mice. Here, MYH11 is linked to pulmonary arterial hypertension.